NCT01691482View on ClinicalTrials.gov

A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium

PHASE4CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

July 23, 2012

Primary Completion Date

October 1, 2012

Study Completion Date

October 22, 2012

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Albuterol/salbutamol

Albuterol/salbutamol (daily)

DRUG

Ipratropium

Ipratropium (daily)

Trial Locations (2)

29303

GSK Investigational Site, Spartanburg

M23 9LT

GSK Investigational Site, Manchester

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01691482 - A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium | Biotech Hunter | Biotech Hunter